Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNMK

GenMark Diagnostics (GNMK) Stock Price, News & Analysis

GenMark Diagnostics logo

About GenMark Diagnostics Stock (NASDAQ:GNMK)

Advanced Chart

Key Stats

Today's Range
$24.04
$24.04
50-Day Range
$23.89
$24.04
52-Week Range
$8.42
$24.25
Volume
N/A
Average Volume
2.70 million shs
Market Capitalization
$1.76 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GenMark Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

GNMK Stock News Headlines

Quest Diagnostics Incorporated (DGX)
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Genmark Diagnos Share Chat
See More Headlines

GNMK Stock Analysis - Frequently Asked Questions

GenMark Diagnostics, Inc. (NASDAQ:GNMK) issued its quarterly earnings data on Thursday, February, 25th. The medical equipment provider reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.04. The medical equipment provider had revenue of $50.08 million for the quarter, compared to analyst estimates of $50 million. GenMark Diagnostics had a negative trailing twelve-month return on equity of 39.36% and a negative net margin of 16.95%.

Based on aggregate information from My MarketBeat watchlists, some other companies that GenMark Diagnostics investors own include Advanced Micro Devices (AMD), Novavax (NVAX), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Pfizer (PFE), Enphase Energy (ENPH) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
2/25/2021
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GNMK
CIK
1487371
Fax
N/A
Employees
618
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.35 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$88.02 million
Price / Cash Flow
N/A
Book Value
$0.21 per share
Price / Book
114.48

Miscellaneous

Free Float
N/A
Market Cap
$1.76 billion
Optionable
Optionable
Beta
3.02

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:GNMK) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners